The effect of preoperative oral magnesium oxide on the severity of postoperative pain among women undergoing hysterectomy

2022 ◽  
Author(s):  
Morteza Hashemian ◽  
Alireza Mirkheshti ◽  
Amirhossein Mirafzal ◽  
Habibeh Ahmadipour ◽  
Mohammad Amirhosseini Nasehabad
Keyword(s):  
Postoperative Pain ◽  
Magnesium Oxide ◽  
Oral Magnesium

scholarly journals Gitelmanʼs syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration

Medicine ◽  
2019 ◽  
Vol 98 (28) ◽  
pp. e16408
Author(s):  
Aika Miya ◽  
Akinobu Nakamura ◽  
Hiraku Kameda ◽  
Kandai Nozu ◽  
Hideaki Miyoshi ◽  
...  
Keyword(s):  
Magnesium Oxide ◽  
Oral Magnesium

Management of an i.v. fluid shortage through use of electronic medical record alerts

2020 ◽  
Vol 77 (7) ◽  
pp. 546-551
Author(s):  
Melissa Sandler ◽  
Jared Cavanaugh ◽  
Ted Walton ◽  
Laurie Cavendish ◽  
Kruti Shah
Keyword(s):  
Oral Dose ◽  
Magnesium Sulfate ◽  
Medical Record ◽  
Magnesium Oxide ◽  
Electronic Medical Record ◽  
Primary Outcome ◽  
Serum Magnesium ◽  
Magnesium Concentration ◽  
Drug Shortage ◽  
Oral Magnesium

Abstract Purpose Evaluation of mechanisms used to cope with an i.v. fluid shortage to determine if prescribing habits were changed and if substitution of an i.v. dose of magnesium with an oral dose impacted patient outcomes. Methods A single-center, retrospective analysis of electronic medical record (EMR) alerts and medical records covering 6-month periods before and during an i.v. fluid shortage was conducted. Records of adult medical and surgical inpatients admitted during these periods who had an order for i.v. or oral magnesium were screened for inclusion. The primary outcome of part 1 of the study was the percent acceptance of drug shortage–related EMR alert recommendations associated with i.v. magnesium. The primary outcome of part 2 of the study was the change in serum magnesium concentration (SMC) after an i.v. or oral dose of magnesium was administered. Results Of the 7,476 EMR alerts generated during provider ordering of i.v. magnesium products, 4.8% resulted in the provider accepting the recommendation to switch to an oral alternative, 89% resulted in continuation of an i.v. magnesium order, and 6.2% resulted in order cancellation. Among patients who received magnesium doses, SMC values increased by a mean (SD) of 0.135 (0.08) mg/dL per gram of i.v. magnesium sulfate administered (n = 251), compared to an increase of 0.058 (0.08) mg/dL per 400-mg tablet of magnesium oxide administered (n = 42). Conclusion Acceptance of the EMR alert recommendations was low. Both i.v. magnesium sulfate and oral magnesium oxide are viable options for increasing SMC.

Oral magnesium oxide for treatment of hot flashes in women undergoing treatment for breast cancer: A pilot study.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e19530-e19530
Author(s):  
J. Herrada ◽  
A. Gupta ◽  
A. F. Campos-Gines ◽  
L. S. Noble ◽  
M. M. Landeros ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Pilot Study ◽  
Magnesium Oxide ◽  
Hot Flashes ◽  
Oral Magnesium

scholarly journals Study of the compatibility of oral magnesium oxide preparations sold in Japan with the ICH-Q3D guideline for elemental impurities

2021 ◽  
Author(s):  
Mitsutoshi Satoh ◽  
Kimitaka Motokawa ◽  
Yoshihiro Uesawa ◽  
Yoichi Ishikawa ◽  
Hideki Maeda ◽  
...  
Keyword(s):  
Magnesium Oxide ◽  
Elemental Impurities ◽  
Oral Magnesium

Oral Magnesium Oxide Prophylaxis of Frequent Migrainous Headache in Children: A Randomized, Double-Blind, Placebo-Controlled Trial

2003 ◽  
Vol 43 (6) ◽  
pp. 601-610 ◽  
Author(s):  
Fong Wang ◽  
Stephen K. Van Den Eeden ◽  
Lynn M. Ackerson ◽  
Susan E. Salk ◽  
Robyn H. Reince ◽  
...  
Keyword(s):  
Magnesium Oxide ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Migrainous Headache ◽  
Oral Magnesium
Sign in / Sign up

Export Citation Format

Share Document